- Home
- DSM vs TKNO Comparison
DSM vs TKNO Comparison
Compare DSM & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DSM | TKNO |
|---|---|---|
| Founded | 1989 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 298.5M | 308.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | DSM | TKNO |
|---|---|---|
| Price | $6.05 | $5.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 129.7K | ★ 233.6K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 3.97% | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | N/A | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $5.45 | $1.91 |
| 52 Week High | $6.30 | $6.68 |
Technical Indicators
Market Signals| Indicator | DSM | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 41.17 | 53.02 |
| Support Level | $6.03 | $4.89 |
| Resistance Level | $6.21 | $5.94 |
| Average True Range (ATR) | 0.05 | 0.40 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 13.89 | 26.32 |
Price Performance
Historical ComparisonAbout DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.